Olson, Katherine E.
Abdelmoaty, Mai M.
Namminga, Krista L.
Lu, Yaman
Obaro, Helen
Santamaria, Pamela
Mosley, R. Lee
Gendelman, Howard E.
Clinical trials referenced in this document:
Documents that mention this clinical trial
An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
https://doi.org/10.1186/s40035-023-00361-1
Funding for this research was provided by:
NINDS (R01NS034239-25)
University of Nebraska Foundation, Private Donations
Article History
Received: 5 February 2023
Accepted: 4 May 2023
First Online: 22 May 2023
Declarations
:
: The study was reviewed and approved by UNMC Institutional Review Board and all subjects signed an informed consent form.
: Not applicable.
: The authors declare no conflicts of interest.